News Image

Balancing Dividends and Fundamentals: The Case of NASDAQ:GILD.

By Mill Chart

Last update: Mar 5, 2024

Our stock screening tool has identified GILEAD SCIENCES INC (NASDAQ:GILD) as a strong dividend contender with robust fundamentals. NASDAQ:GILD exhibits commendable financial health and profitability, all while offering a sustainable dividend. Let's delve into each aspect below.

A Closer Look at Dividend for NASDAQ:GILD

ChartMill provides a Dividend Rating for every stock, ranging from 0 to 10. This rating assesses various dividend aspects, including yield, growth, and sustainability. NASDAQ:GILD earns a 7 out of 10:

  • With a Yearly Dividend Yield of 4.27%, GILD is a good candidate for dividend investing.
  • GILD's Dividend Yield is rather good when compared to the industry average which is at 21.23. GILD pays more dividend than 98.82% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 2.44, GILD pays a better dividend.
  • The dividend of GILD is nicely growing with an annual growth rate of 7.27%!
  • GILD has paid a dividend for at least 10 years, which is a reliable track record.
  • GILD has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.

A Closer Look at Health for NASDAQ:GILD

ChartMill employs its own Health Rating for stock assessment. This rating, ranging from 0 to 10, is calculated by examining various liquidity and solvency ratios. In the case of NASDAQ:GILD, the assigned 5 reflects its health status:

  • GILD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

What does the Profitability looks like for NASDAQ:GILD

ChartMill assigns a Profitability Rating to every stock. This score ranges from 0 to 10 and evaluates the different profitability ratios and margins, both absolutely, but also relative to the industry peers. NASDAQ:GILD scores a 7 out of 10:

  • The Return On Assets of GILD (9.12%) is better than 97.14% of its industry peers.
  • With an excellent Return On Equity value of 24.90%, GILD belongs to the best of the industry, outperforming 97.81% of the companies in the same industry.
  • The Return On Invested Capital of GILD (12.76%) is better than 97.31% of its industry peers.
  • Looking at the Profit Margin, with a value of 20.89%, GILD belongs to the top of the industry, outperforming 97.14% of the companies in the same industry.
  • The Operating Margin of GILD (29.83%) is better than 97.98% of its industry peers.
  • Looking at the Gross Margin, with a value of 77.80%, GILD belongs to the top of the industry, outperforming 86.03% of the companies in the same industry.

Our Best Dividend screener lists more Best Dividend stocks and is updated daily.

Our latest full fundamental report of GILD contains the most current fundamental analsysis.

Disclaimer

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.

Back

GILEAD SCIENCES INC

NASDAQ:GILD (4/22/2024, 7:04:09 PM)

After market: 66.95 0 (0%)

66.95

+0.19 (+0.28%)

GILD News

News Image18 hours ago - InvestorPlaceUndervalued Icons: 3 Household Names Trading at Steep Discounts

Three of Wall Street's undervalued stocks could provide a unique blend of stability and long-term growth potential.

News Image4 days ago - Zacks Investment ResearchGilead Sciences (GILD) Increases Despite Market Slip: Here's What You Need to Know

Gilead Sciences (GILD) closed the most recent trading day at $66.76, moving +0.91% from the previous trading session.

News Image4 days ago - Market News VideoInteresting GILD Put And Call Options For July 19th
News Image5 days ago - Zacks Investment ResearchGilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Gilead Sciences (GILD) closed at $66.16 in the latest trading session, marking a -1.15% move from the prior day.

News Image5 days ago - Zacks Investment ResearchAnalysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for

Gilead (GILD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

News Image6 days ago - ChartmillWhy the dividend investor may take a look at NASDAQ:GILD.

Uncovering Dividend Opportunities with GILEAD SCIENCES INC (NASDAQ:GILD).

News Image8 days ago - Market News VideoKKR Moves Up In Market Cap Rank, Passing Gilead Sciences
News Image8 days ago - The Motley FoolBetter Growth Play: Merck or The Vanguard Growth Index Fund?

Merck's shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?

News Image8 days ago - The Motley FoolShould You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?

Dividend stocks can be a smart way to ride out market volatility.

News Image12 days ago - Market News VideoGILD May 31st Options Begin Trading
News Image12 days ago - FinancialNewsMediaBiotech Innovations Paving the Way in Breast Cancer Fight

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GILD),(NASDAQ:GTHX),(NASDAQ:AZN),(NASDAQ:HOLX) EQNX::TICKER_END

News Image12 days ago - USA News GroupBiotech Innovations Paving the Way in Breast Cancer Fight

/PRNewswire/ -- USA News Group – The American Cancer Society is projecting 2024 to be the first year ever for the US to have more than 2 million new cases,...

GILD Links
Follow us for more